Search research articles
Contact Us
Filters
Showing results (91-100 of 98) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 98 results.
Journal of Virology
|
August 25, 2017
PrP P102L and Nearby Lysine Mutations Promote Spontaneous <i>In Vitro</i> Formation of Transmissible Prions
Allison Kraus, Gregory J Raymond, Brent Race, et al.
Journal of Virology
|
October 1, 1994
trans activation by the full-length E2 proteins of human papillomavirus type 16 and bovine papillomavirus type 1 in vitro and in vivo: cooperation with activation domains of cellular transcription factors
M Ushikai, M J Lace, Y Yamakawa, et al.
Journal of Medicinal Chemistry
|
September 16, 2021
Indole Chloropyridinyl Ester-Derived SARS-CoV-2 3CLpro Inhibitors: Enzyme Inhibition, Antiviral Efficacy, Structure-Activity Relationship, and X-ray Structural Studies
Arun K Ghosh, Jakka Raghavaiah, Dana Shahabi, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
September 2, 2017
RT-QuIC Assays for Prion Disease Detection and Diagnostics
Christina D Orrù, Bradley R Groveman, Andrew G Hughson, et al.
Molecules (Basel, Switzerland)
|
October 13, 2021
Chloropyridinyl Esters of Nonsteroidal Anti-Inflammatory Agents and Related Derivatives as Potent SARS-CoV-2 3CL Protease Inhibitors
Arun K Ghosh, Dana Shahabi, Monika Yadav, et al.
Nature Communications
|
January 29, 2021
A small molecule compound with an indole moiety inhibits the main protease of SARS-CoV-2 and blocks virus replication
Shin-Ichiro Hattori, Nobuyo Higashi-Kuwata, Hironori Hayashi, et al.
Biorxiv : the Preprint Server for Biology
|
September 16, 2020
Discovery of a Novel Inhibitor of Coronavirus 3CL Protease for the Potential Treatment of COVID-19
Britton Boras, Rhys M Jones, Brandon J Anson, et al.
Nature Communications
|
October 19, 2021
Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19
Britton Boras, Rhys M Jones, Brandon J Anson, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 98) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 98 results.
Journal of Virology
|
August 25, 2017
PrP P102L and Nearby Lysine Mutations Promote Spontaneous <i>In Vitro</i> Formation of Transmissible Prions
Allison Kraus, Gregory J Raymond, Brent Race, et al.
Journal of Virology
|
October 1, 1994
trans activation by the full-length E2 proteins of human papillomavirus type 16 and bovine papillomavirus type 1 in vitro and in vivo: cooperation with activation domains of cellular transcription factors
M Ushikai, M J Lace, Y Yamakawa, et al.
Journal of Medicinal Chemistry
|
September 16, 2021
Indole Chloropyridinyl Ester-Derived SARS-CoV-2 3CLpro Inhibitors: Enzyme Inhibition, Antiviral Efficacy, Structure-Activity Relationship, and X-ray Structural Studies
Arun K Ghosh, Jakka Raghavaiah, Dana Shahabi, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
September 2, 2017
RT-QuIC Assays for Prion Disease Detection and Diagnostics
Christina D Orrù, Bradley R Groveman, Andrew G Hughson, et al.
Molecules (Basel, Switzerland)
|
October 13, 2021
Chloropyridinyl Esters of Nonsteroidal Anti-Inflammatory Agents and Related Derivatives as Potent SARS-CoV-2 3CL Protease Inhibitors
Arun K Ghosh, Dana Shahabi, Monika Yadav, et al.
Nature Communications
|
January 29, 2021
A small molecule compound with an indole moiety inhibits the main protease of SARS-CoV-2 and blocks virus replication
Shin-Ichiro Hattori, Nobuyo Higashi-Kuwata, Hironori Hayashi, et al.
Biorxiv : the Preprint Server for Biology
|
September 16, 2020
Discovery of a Novel Inhibitor of Coronavirus 3CL Protease for the Potential Treatment of COVID-19
Britton Boras, Rhys M Jones, Brandon J Anson, et al.
Nature Communications
|
October 19, 2021
Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19
Britton Boras, Rhys M Jones, Brandon J Anson, et al.
Page
of 10